Trevi Therapeutics, Inc. · NASDAQ:TRVI

Rubric Capital Management LP's stake in Trevi Therapeutics, Inc. fell to 4.71% (Schedule 13G/A)

Event Dec 31, 2024 · Filed Feb 13, 2025

Rubric Capital Management LP's stake in Trevi Therapeutics, Inc. fell to 4.71%, 4,205,129 shares, as a passive investor on Dec 31, 2024. Filed Feb 13, 2025 (Schedule 13G/A).

Stake
4.71%
Shares
4,205,129
Intent
Passive
What changed
Fell below 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Rubric Capital Management LP4.71%4,205,129
David Rosen4.71%4,205,129

Source

View original at SEC

Related